sphingosine-1-phosphate and Nephritis

sphingosine-1-phosphate has been researched along with Nephritis* in 1 studies

Other Studies

1 other study(ies) available for sphingosine-1-phosphate and Nephritis

ArticleYear
Farnesoid X receptor prevents neutrophil extracellular traps via reduced sphingosine-1-phosphate in chronic kidney disease.
    American journal of physiology. Renal physiology, 2023, Dec-01, Volume: 325, Issue:6

    Farnesoid X receptor (FXR) activation reduces renal inflammation, but the underlying mechanisms remain elusive. Neutrophil extracellular traps (NETs) are webs of DNA formed when neutrophils undergo specialized programmed cell death (NETosis). The signaling lipid sphingosine-1-phosphate (S1P) stimulates NETosis via its receptor on neutrophils. Here, we identify FXR as a negative regulator of NETosis via repressing S1P signaling. We determined the effects of the FXR agonist obeticholic acid (OCA) in mouse models of adenosine phosphoribosyltransferase (APRT) deficiency and Alport syndrome, both genetic disorders that cause chronic kidney disease. Renal FXR activity is greatly reduced in both models, and FXR agonism reduces disease severity. Renal NETosis and sphingosine kinase 1 (

    Topics: Animals; Biomarkers; Extracellular Traps; Female; Humans; Inflammation; Male; Mice; Nephritis; Renal Insufficiency, Chronic; Sphingosine

2023